← Back to Clinical Trials
Recruiting NCT06765772

NCT06765772 Combined Ultrasound Guided Bilateral Rectus Sheath and Erector Spinae Plain Blocks Versus Erector Spinae Plain Block for Intra and Postoperative Analgesia in Elective Abdominoplastic Surgeries. a Randomized Controlled Double Blinded Trial.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06765772
Status Recruiting
Phase —
Sponsor Cairo University
Condition Abdominoplasty
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-12-01
Primary Completion 2025-06

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Erector spinae plane blockRectus sheath block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-12-01 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trail is to determine if bilateral erector spinae plane block alone can provide good perioperative analgesia for abdominoplastic surgery patients or it is better to give combined bilateral rectus sheath and erector spinae plane blocks to achieve effective intraoperative and postoperative analgesia with minimal morphine consumption in such operations in which there is an extensive surgical dissection and a high risk of respiratory problems.

Eligibility Criteria

Inclusion Criteria: * patients Age from 21 to 60 years ,Male and female patients ,ASA I, II patients scheduled for elective abdominoplastic surgeries during the study duration. Exclusion Criteria: * Patient refusal, Age less than 21 and above 60 years old, ASA III, IV patients., Infection at the site of injection, Opioid addiction, Allergy to any used substances (lidocaine, bupivacaine)., Preexisting severe or uncontrolled respiratory, renal or cardiac disease. , INR more than 1.5 and platelets less than 100000.

Contact & Investigator

Central Contact

yahya Mohamed Hammad, MD

✉ yahya196cm@hotmail.com

📞 00201114048081

Principal Investigator

Hassan Mohamed Ali, Phd

STUDY DIRECTOR

Professor of anesthesia Cairo university faculty of medicine

Frequently Asked Questions

Who can join the NCT06765772 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 60 Years, studying Abdominoplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06765772 currently recruiting?

Yes, NCT06765772 is actively recruiting participants. Contact the research team at yahya196cm@hotmail.com for enrollment information.

Where is the NCT06765772 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06765772 clinical trial?

NCT06765772 is sponsored by Cairo University. The principal investigator is Hassan Mohamed Ali, Phd at Professor of anesthesia Cairo university faculty of medicine. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology